BHI News Section Archives - Page 95 of 1201

News

April 25, 2023

Germantown’s Seraxis Presents Successful Results Using Synthetic Replacement Endocrine Clusters for Type 1 Diabetes

GERMANTOWN, Md., April 25, 2023 (Newswire.com) - Seraxis Inc., a pre-clinical stage company with a best-in-class islet replacement therapy for insulin-dependent…

Andy

Love0

News

April 25, 2023

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO,…

Andy

Love0

News

April 25, 2023

Biggest Risk Factors for Emerging and Mid-market Biopharma Companies, Costly Clinical Trial Delays

The value of life-saving drugs for patients suffering from serious diseases is priceless. But the current economic environment is stifling…

Andy

Love0

News

April 24, 2023

JLABS Event to Explore Breakthroughs in Vaccinations: Overcoming Seasonal Dependencies

JLABS is taking the lead in exploring new and innovative approaches to vaccinations with their upcoming event, "Breaking Dependencies on…

Andy

Love0

News

April 24, 2023

Johns Hopkins creates new $100,000 annual prize to support student entrepreneurs | Hub

Johns Hopkins University has launched a new, annual award to support promising business ventures developed by student entrepreneurs—and to encourage…

admin

Love0

News

April 24, 2023

CBRE – 2023 Life Sciences Reports

After record years in 2020 and 2021, growth of the U.S. life sciences industry has returned to a more normal…

admin

Love0

News

April 21, 2023

Rich Bendis to Discuss U.S. Capital Region’s Role in APEC Dialogue on Medical Product Supply Chain on April 25th at USP

BioHealth Innovation is proud to announce that Rich Bendis, Founder and CEO, will be…

Andy

Love0

News

April 21, 2023

Mason engineers and partners receive $3M award to build new technology for personalized musculoskeletal injury rehabilitation to support troop readiness

April 20, 2023 / By Katie Maney Musculoskeletal injury (MSKI) is the most common form of medical injury experienced by…

Andy

Love0

News

April 21, 2023

Gain Therapeutics Revolutionary Drug Discovery: Combining Physics, Biochemistry, and Supercomputing

Discovering treatments for patients that currently have no available disease-modifying options is the priority of Gain Therapeutics. Specifically, there is…

Andy

Love0

News

April 20, 2023

Maryland General Assembly passes legislation to create TEDCO Equitech fund – BizJournals

By Matt Hooke - Reporter April 20, 2023, 03:04pm EDT The Maryland General Assembly passed a bill that would establish a…

Andy

Love0

BHI News Section

Germantown’s Seraxis Presents Successful Results Using Synthetic Replacement Endocrine Clusters for Type 1 Diabetes

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Biggest Risk Factors for Emerging and Mid-market Biopharma Companies, Costly Clinical Trial Delays

JLABS Event to Explore Breakthroughs in Vaccinations: Overcoming Seasonal Dependencies

Johns Hopkins creates new $100,000 annual prize to support student entrepreneurs | Hub

CBRE – 2023 Life Sciences Reports

Rich Bendis to Discuss U.S. Capital Region’s Role in APEC Dialogue on Medical Product Supply Chain on April 25th at USP

Mason engineers and partners receive $3M award to build new technology for personalized musculoskeletal injury rehabilitation to support troop readiness

Gain Therapeutics Revolutionary Drug Discovery: Combining Physics, Biochemistry, and Supercomputing

Maryland General Assembly passes legislation to create TEDCO Equitech fund – BizJournals

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search